Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia
Marie-Émilie Dourthe, Florence Rabian, Karima Yakouben, Florian Chevillon, Aurélie Cabannes‐Hamy, Françoise Méchinaud, Audrey Grain, Delphine Chaillou, Ilhem Rahal, Sophie Caillat‐Zucman, Emmanuelle Lesprit, J. Naudin, Julie Roupret‐Serzec, Nathalie Parquet, Anne Brignier, Valérie Guérin‐El Khourouj, Élodie Lainey, Aurélie Caye‐Eude, Hélène Cavé, Emmanuelle Clappier, Stéphanie Mathis, Élie Azoulay, Jean Hugues Dalle, Nathalie Dhédin, Isabelle Madelaine, Jérôme Larghero, Nicolas Boissel, André Baruchel
Topics & Concepts
MedicineBlinatumomabInternal medicineCumulative incidenceCytokine release syndromeMinimal residual diseaseAcute lymphocytic leukemiaGastroenterologyImmunologyOncologyRefractory (planetary science)ImmunotherapyLeukemiaLymphoblastic LeukemiaTransplantationCancerAstrobiologyChimeric antigen receptorPhysicsCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchVirus-based gene therapy research